Skip to content

Obeserve Study on the Regulation of Appetite in Female Abdominal Obese Patients by Shu Mu Acupoint Catgut Embedding

Obeserve Study on the Regulation of Appetite in Female Abdominal Obese Patients by Shu Mu Acupoint Catgut Embedding

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082758
Enrollment
Unknown
Registered
2024-04-07
Start date
2024-04-10
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Acupoint Catgut Embedding Group:Acupoint catqut embedding
Sham Acupoint Catqut Embedding Group:Buried threads in syringes not loaded with protein threads

Sponsors

The Second Affiliated Hospital of Yunnan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-45 years old, female, receiving compulsory education for at least 6 years; (2) Meet the diagnostic criteria for abdominal obesity; (3) Appetite VAS score =7 or appetite VAS score =3; (4) Agree to participate in this study and sign written informed consent and acupoint embedding informed consent; (5) Did not participate in other tests within three months.

Exclusion criteria

Exclusion criteria: (1) Patients with extreme obesity (BMI=40kg/m2); (2) Secondary obesity, such as: obesity caused by endocrine diseases (Cushing's syndrome, thyroid disease, hypothalamus, pituitary disease, genital disease, etc.) or drug treatment (glucocorticoids, antipsychotics); (3) Complicated with serious primary diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system and other organic diseases. Or patients with essential hypertension and can not be effectively controlled; Or have a history of stroke and can not exercise weight control within 3 months; (4) Patients with a history of major mental trauma, serious mental or neurological diseases who are unable or unwilling to cooperate; (5) People with bleeding tendencies, allergies to alcohol, animal protein or immune diseases; (6) Pregnant and lactating women who have had fertility requirements within the last 6 months or who are unable to obtain adequate contraception; (7) A history of surgical treatment for obesity; (8) Accepted other weight loss methods or participated in similar researchers within 3 months; (9) Those who have previously undergone major intestinal resection or major gastrointestinal surgery; (10) Those who have taken antibiotics for 3 days or more in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Appetite visual analogue score;

Secondary

MeasureTime frame
Body mass index;Waist circumference;Body weight;Gastrointestinal symptom rating scale;Self-Rating Anxiety Scale;Self-Rating Depression Scale;

Countries

China

Contacts

Public ContactGuo Taipin

The Second Affiliated Hospital of Yunnan University of Chinese Medicine; Yunnan University of Chinese Medicine

gtphncs@126.com+86 184 8727 2658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026